Chicago, IL – According to filings with the U.S. Securities and Exchange Commission, Kalderos is raising $28,000,001.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jeremy Docken played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Kalderos

Kalderos delivers unifying technology that solves problems facing the U.S. healthcare system. We work with healthcare providers, manufacturers, payers and others to increase transparency and restore trust enabling everyone to focus on improving the health of people. Kalderos has built the nation’s first Drug Discount Management platform, with a focus on simplifying the complex coordination of drug discount programs. We provide support to providers, manufacturers and payers to ensure the right discount to the right party on the right transaction.

To learn more about Kalderos, visit http://www.kalderos.com/

Contact:
Jeremy Docken, Chief Executive Officer
312-855-2030
jdocken@kalderos.com
https://www.linkedin.com/in/jeremydocken/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved